Prime Capital Investment Advisors, LLC Exact Sciences Corp Transaction History

Prime Capital Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$59.06 - $75.72 $300,261 - $384,960	-5,084 Reduced 57.41%	3,772 $279,000
Q3 2023 Nov 09, 2023	SELL	$65.94 - $99.04 $545,521 - $819,357	-8,273 Reduced 48.3%	8,856 $604,000
Q2 2023 Aug 08, 2023	SELL	$62.68 - $95.05 $22,815 - $34,598	-364 Reduced 2.08%	17,129 $1.61 Million
Q1 2023 May 05, 2023	BUY	$47.19 - $70.77 $825,494 - $1.24 Million	17,493 New	17,493 $1.19 Million
Q4 2019 Feb 04, 2020	SELL	$77.66 - $99.74 $6,212 - $7,979	-80 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$90.37 - $122.49 $7,229 - $9,799	80 New	80 $7,000

667

152M

4.25M

1.89M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.81B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.